Citation Impact
Citing Papers
Comprehensive computational design of ordered peptide macrocycles
2017 StandoutScienceNobel
Actin retrograde flow actively aligns and orients ligand-engaged integrins in focal adhesions
2017 StandoutNobel
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
2006 Standout
Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
2011
Mechanisms of Endocrine Resistance in Breast Cancer
2010
HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas
2006
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas
2009
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Engineering precision nanoparticles for drug delivery
2020 Standout
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
2010
Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells
2003
Tumor-targeting peptides from combinatorial libraries
2016
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Gene amplification in cancer
2006
Cyclin E as a prognostic and predictive marker in breast cancer
2005
Estimation of hormone receptor status and HER2 in cytologic cell blocks from breast cancer using the novel rabbit monoclonal antibodies (SP1, SP2, and SP3)
2009
Breast cancer
2016 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
AKT/PKB Signaling: Navigating Downstream
2007 Standout
The Vascular Basement Membrane as “Soil” in Brain Metastasis
2009
Wound healing and its impairment in the diabetic foot
2005 Standout
Molecular mechanisms of drug resistance
2005
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
2009 StandoutNature
Cancer Metastasis: Building a Framework
2006 Standout
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
2005 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Co‐stimulation of human breast cancer cells with transforming growth factor‐β and tenascin‐C enhances matrix metalloproteinase‐9 expression and cancer cell invasion
2004
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma
2003
Matrix Metalloproteinase-sensitive Multistage Nanogels Promote Drug Transport in 3D Tumor Model
2019
Stimulation‐Dependent Recycling of Integrin β1 Regulated by ARF6 and Rab11
2003
Determination of HER2 amplification in primary breast cancer using dual‐colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens
2010
Multifaceted Roles of Integrins in Breast Cancer Metastasis
2007
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche
2004 Standout
The impact of tumor stroma on drug response in breast cancer
2014
Environment-mediated drug resistance: a major contributor to minimal residual disease
2009
Expression of Integrin αVβ3 in Pancreatic Carcinoma: Relation to MMP-2 Activation and Lymph Node Metastasis
2002
Antiangiogenic therapy—evolving view based on clinical trial results
2012
Integrins as “functional hubs” in the regulation of pathological angiogenesis
2009
Pre-eclampsia
2005 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Autophagy and Aging
2011 Standout
Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis
2002
Microenvironmental regulation of metastasis
2008 Standout
Self-eating and self-killing: crosstalk between autophagy and apoptosis
2007 Standout
The opposing roles of laminin-binding integrins in cancer
2016
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
The Hallmarks of Aging
2013 Standout
Clinical Biomarkers in Oncology
2009
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
2006
Distinct ligand binding sites in integrin α3β1 regulate matrix adhesion and cell–cell contact
2003
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
2008 StandoutNobel
Tumor cell α3β1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis
2004
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network
2015
Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells
2007
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Homeobox D10 Induces Phenotypic Reversion of Breast Tumor Cells in a Three-Dimensional Culture Model
2005
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Breast Cancer Treatment
2019 Standout
Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells.
2003
Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcoma.
2002 StandoutNobel
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
α3β1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression
2005
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Mechanisms of Endocytosis
2009 Standout
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Interstitial guidance of cancer invasion
2011
Works of Simonetta Buglioni being referenced
HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care
2011
Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy
2000
Contribution of fluorescence in situ hybridization to immunohistochemistry for the evaluation of HER-2 in breast cancer
2002
c-Myb and Bcl-x Overexpression Predicts Poor Prognosis in Colorectal Cancer
2001
Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancer
2004
Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl-2
1999
p53 Nuclear Accumulation and Multiploidy Are Adverse Prognostic Factors in Surgically Resected Stage II Colorectal Cancers Independent of Fluorouracil-Based Adjuvant Therapy
2001
Induction of ErbB-3 Expression by α6β4 Integrin Contributes to Tamoxifen Resistance in ERβ1-Negative Breast Carcinomas
2008
Prognostic relevance of altered Fas (CD95)-system in human breast cancer
2000
Bcl‐2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity
2001
Identification of an Adverse Biologic Profile in Cyclophosphamide/Metotrexate/5-Fluorouracil Treated Early Stage Breast Cancer Patients by Immunohistochemical Analysis of PI3K/p-Akt Pathway Alterations.
2009
The α3β1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (mmp‐9) activity
2000
Chromogenic In Situ Hybridization to Detect HER-2/neu Gene Amplification in Histological and ThinPrep®-Processed Breast Cancer Fine-Needle Aspirates: A Sensitive and Practical Method in the Trastuzumab Era
2006
The α3β1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (mmp-9) activity
2000
Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy
2004